🕵️ Aquestive Therapeutics, Inc. ($AQST)
SEC insider & ownership activity, last 12 months · CIK 1398733 · every row links its SEC filing
Over the last 12 months insiders sold $3.7M with no open-market buying against it. Daniel Barber sold $1.5M (Sep–Jul). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 9 sellers, $3.7M (20 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Daniel Barber | 0 | – | 7 | $1.5M | Jul 16, 2026 |
| Jung Cassie | 0 | – | 3 | $976K | Mar 10, 2026 |
| Peter E. Boyd | 0 | – | 4 | $337K | Mar 10, 2026 |
| Toth A Ernest Jr. | 0 | – | 1 | $243K | Mar 10, 2026 |
| Lori J. Braender | 0 | – | 1 | $167K | Mar 10, 2026 |
| Carl N. Kraus | 0 | – | 1 | $142K | Oct 15, 2025 |
| Julie Krop | 0 | – | 1 | $125K | Jun 23, 2026 |
| Cioffi Melina | 0 | – | 1 | $106K | Mar 10, 2026 |
| Korczynski Sherry | 0 | – | 1 | $66K | Mar 10, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Douglas K. Bratton | 11.1% | 13G | Feb 13, 2025 | filing ↗ | |
| Blackrock, Inc. | 6.4% | 13G | Jul 27, 2026 | filing ↗ | |
| RTW Investments, LP | 5.2% | 13G | Nov 14, 2025 | filing ↗ | |
| Roderick Wong | 5.2% | 13G | Nov 14, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Daniel Barber | $101K | Jul 15, 2026 | filing ↗ |
| Julie Krop | $118K | Jun 23, 2026 | filing ↗ |
| Daniel Barber | $104K | Jun 15, 2026 | filing ↗ |
| Daniel Barber | $39K | May 15, 2026 | filing ↗ |
| Carl N. Kraus | $286K | Nov 17, 2025 | filing ↗ |
| Carl N. Kraus | $279K | Oct 15, 2025 | filing ↗ |
| Cassie Jung | $465K | Oct 15, 2025 | filing ↗ |
| Peter Boyd | $70K | Oct 15, 2025 | filing ↗ |
| Daniel Barber | $480K | Sep 26, 2025 | filing ↗ |
| Peter Boyd | $63K | Sep 26, 2025 | filing ↗ |
| Daniel R Barber | $2K | Sep 19, 2025 | filing ↗ |
| Peter E. Boyd | $80K | Sep 5, 2025 | filing ↗ |
| Cassie Jung | $246K | Sep 4, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Material agreement (1.01) | May 12, 2026 | filing ↗ |
| Agreement terminated (1.02) | May 12, 2026 | filing ↗ |
| Earnings (2.02) | May 12, 2026 | filing ↗ |
| New financial obligation (2.03) | May 12, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 16, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 16, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 3, 2026 | filing ↗ |
| Earnings (2.02) | Mar 3, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 30, 2026 | filing ↗ |
| Other events (8.01) | Jan 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Earnings (2.02) | Nov 5, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |